Do analysts prefer RDGT or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, RDGT or MEDS?

Ridgetech has higher revenue and earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A Wellgistics Health $23.34M 0.37 -$101.28M -$46.13 N/A

Is RDGT or MEDS more profitable?

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Wellgistics Health -1,100.16% N/A -171.81%

Do analysts rate HKPD or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, HKPD or MEDS?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.09 -$1.14M N/A N/A Wellgistics Health $23.34M 0.37 -$101.28M -$46.13 N/A

Is HKPD or MEDS more profitable?

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Hong Kong Pharma Digital Technology N/A N/A N/A Wellgistics Health -1,100.16% N/A -171.81%

Do analysts prefer MEDS or MCK?

McKesson has a consensus target price of $973.44, indicating a potential upside of 8.34%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Wellgistics Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 McKesson 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78

Does the media prefer MEDS or MCK?

In the previous week, McKesson had 17 more articles in the media than Wellgistics Health. MarketBeat recorded 25 mentions for McKesson and 8 mentions for Wellgistics Health. McKesson's average media sentiment score of 0.88 beat Wellgistics Health's score of 0.37 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wellgistics Health 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral McKesson 18 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Do analysts prefer COR or MEDS?

Cencora presently has a consensus target price of $370.85, suggesting a potential upside of 14.85%. Given Cencora's stronger consensus rating and higher possible upside, equities analysts clearly believe Cencora is more favorable than Wellgistics Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cencora 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.81 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, COR or MEDS?

Cencora has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $638.56M 96.50 $1.55B $13.46 23.99 Wellgistics Health $23.34M 0.37 -$101.28M -$46.13 N/A

Does the media prefer COR or MEDS?

In the previous week, Cencora had 6 more articles in the media than Wellgistics Health. MarketBeat recorded 14 mentions for Cencora and 8 mentions for Wellgistics Health. Cencora's average media sentiment score of 0.99 beat Wellgistics Health's score of 0.37 indicating that Cencora is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 9 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Wellgistics Health 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer CAH or MEDS?

Cardinal Health currently has a consensus price target of $266.56, indicating a potential upside of 14.79%. Given Cardinal Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Cardinal Health is more favorable than Wellgistics Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.84 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor CAH or MEDS?

In the previous week, Cardinal Health had 6 more articles in the media than Wellgistics Health. MarketBeat recorded 14 mentions for Cardinal Health and 8 mentions for Wellgistics Health. Cardinal Health's average media sentiment score of 1.09 beat Wellgistics Health's score of 0.37 indicating that Cardinal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 10 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Wellgistics Health 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Trading of Wellgistics Health was halted at 02:01 PM EST due to "LULD Pause".

Wellgistics Health (MEDS) Competitors

$2.73 +1.86 (+215.50%)

As of 01:56 PM Eastern

Compare

MEDS vs. RDGT, HKPD, MCK, COR, and CAH

Should you buy Wellgistics Health stock or one of its competitors? Wellgistics Health's main competitors and comparable companies include Ridgetech (RDGT), Hong Kong Pharma Digital Technology (HKPD), McKesson (MCK), Cencora (COR), and Cardinal Health (CAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Wellgistics Health compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

Ridgetech has higher revenue and earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
Wellgistics Health	$23.34M	0.37	-$101.28M	-$46.13	N/A

In the previous week, Wellgistics Health had 7 more articles in the media than Ridgetech. MarketBeat recorded 8 mentions for Wellgistics Health and 1 mentions for Ridgetech. Ridgetech's average media sentiment score of 1.89 beat Wellgistics Health's score of 0.37 indicating that Ridgetech is being referred to more favorably in the media.

Company	Overall Sentiment
Ridgetech	Very Positive
Wellgistics Health	Neutral

Ridgetech has a beta of -0.08, suggesting that its share price is 108% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.77, suggesting that its share price is 277% less volatile than the broader market.

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Comparatively, 27.0% of Wellgistics Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Wellgistics Health	-1,100.16%	N/A	-171.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Ridgetech beats Wellgistics Health on 7 of the 10 factors compared between the two stocks.

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

5.7% of Wellgistics Health shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Wellgistics Health had 6 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 8 mentions for Wellgistics Health and 2 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.44 beat Wellgistics Health's score of 0.37 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Positive
Wellgistics Health	Neutral

Hong Kong Pharma Digital Technology has a beta of 2.23, indicating that its stock price is 123% more volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.77, indicating that its stock price is 277% less volatile than the broader market.

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.09	-$1.14M	N/A	N/A
Wellgistics Health	$23.34M	0.37	-$101.28M	-$46.13	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Wellgistics Health	-1,100.16%	N/A	-171.81%

Summary

Hong Kong Pharma Digital Technology and Wellgistics Health tied by winning 5 of the 10 factors compared between the two stocks.

How does Wellgistics Health compare to McKesson?

Wellgistics Health (NASDAQ:MEDS) and McKesson (NYSE:MCK) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

McKesson has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.37	-$101.28M	-$46.13	N/A
McKesson	$403.43B	0.26	$4.76B	$37.37	24.04

McKesson has a net margin of 1.12% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
McKesson	1.12%	-253.21%	5.90%

In the previous week, McKesson had 17 more articles in the media than Wellgistics Health. MarketBeat recorded 25 mentions for McKesson and 8 mentions for Wellgistics Health. McKesson's average media sentiment score of 0.88 beat Wellgistics Health's score of 0.37 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Wellgistics Health	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
McKesson	18 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

5.7% of Wellgistics Health shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Wellgistics Health has a beta of -1.77, suggesting that its share price is 277% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market.

McKesson has a consensus target price of $973.44, indicating a potential upside of 8.34%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Wellgistics Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

Summary

McKesson beats Wellgistics Health on 13 of the 16 factors compared between the two stocks.

How does Wellgistics Health compare to Cencora?

Cencora (NYSE:COR) and Wellgistics Health (NASDAQ:MEDS) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

Cencora has a net margin of 0.79% compared to Wellgistics Health's net margin of -1,100.16%. Cencora's return on equity of 125.45% beat Wellgistics Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.79%	125.45%	4.18%
Wellgistics Health	-1,100.16%	N/A	-171.81%

Cencora has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$638.56M	96.50	$1.55B	$13.46	23.99
Wellgistics Health	$23.34M	0.37	-$101.28M	-$46.13	N/A

Cencora has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.77, suggesting that its stock price is 277% less volatile than the broader market.

In the previous week, Cencora had 6 more articles in the media than Wellgistics Health. MarketBeat recorded 14 mentions for Cencora and 8 mentions for Wellgistics Health. Cencora's average media sentiment score of 0.99 beat Wellgistics Health's score of 0.37 indicating that Cencora is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	9 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Wellgistics Health	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

97.5% of Cencora shares are held by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are held by institutional investors. 0.4% of Cencora shares are held by company insiders. Comparatively, 27.0% of Wellgistics Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cencora presently has a consensus target price of $370.85, suggesting a potential upside of 14.85%. Given Cencora's stronger consensus rating and higher possible upside, equities analysts clearly believe Cencora is more favorable than Wellgistics Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Cencora beats Wellgistics Health on 15 of the 16 factors compared between the two stocks.

How does Wellgistics Health compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Wellgistics Health (NASDAQ:MEDS) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

In the previous week, Cardinal Health had 6 more articles in the media than Wellgistics Health. MarketBeat recorded 14 mentions for Cardinal Health and 8 mentions for Wellgistics Health. Cardinal Health's average media sentiment score of 1.09 beat Wellgistics Health's score of 0.37 indicating that Cardinal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	10 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Wellgistics Health	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by insiders. Comparatively, 27.0% of Wellgistics Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cardinal Health has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$254.25B	0.21	$1.71B	$7.23	32.12
Wellgistics Health	$23.34M	0.37	-$101.28M	-$46.13	N/A

Cardinal Health has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.77, suggesting that its share price is 277% less volatile than the broader market.

Cardinal Health currently has a consensus price target of $266.56, indicating a potential upside of 14.79%. Given Cardinal Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Cardinal Health is more favorable than Wellgistics Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.84
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cardinal Health has a net margin of 0.67% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.67%	-98.53%	4.69%
Wellgistics Health	-1,100.16%	N/A	-171.81%

Summary

Cardinal Health beats Wellgistics Health on 13 of the 16 factors compared between the two stocks.

Get Wellgistics Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MEDS vs. The Competition

Export

Metric	Wellgistics Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$8.74M	$9.90B	$7.17B	$14.37B
Dividend Yield	N/A	2.61%	2.57%	11.71%
P/E Ratio	-0.06	33.88	273.42	25.34
Price / Sales	0.37	5.67	675.88	98.52
Price / Cash	N/A	24.78	28.42	34.96
Price / Book	-0.39	5.35	10.41	6.21
Net Income	-$101.28M	$313.45M	$3.49B	$358.18M
7 Day Performance	213.40%	0.97%	-1.96%	-1.36%
1 Month Performance	-21.10%	-0.78%	-0.23%	-3.42%
1 Year Performance	-96.01%	16.04%	19.03%	5.98%

Wellgistics Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MEDS Wellgistics Health	0.2156 of 5 stars	$2.73 +215.5%	N/A	-98.8%	$8.74M	$23.34M	N/A	31	Gap Down Trading Halted High Trading Volume
RDGT Ridgetech	1.0421 of 5 stars	$0.91 flat	N/A	-99.6%	$3.30M	$132.16M	N/A	980	Gap Down
HKPD Hong Kong Pharma Digital Technology	1.4788 of 5 stars	$0.13 flat	N/A	-90.7%	$1.40M	$13.43M	N/A	19	Positive News Short Interest Decrease Gap Down
MCK McKesson	4.4232 of 5 stars	$907.35 -0.1%	$973.44 +7.3%	+28.1%	$105.79B	$403.43B	24.28	43,000	Analyst Forecast
COR Cencora	4.8233 of 5 stars	$330.52 -0.1%	$370.85 +12.2%	+7.9%	$63.07B	$321.33B	24.56	51,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MEDS) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Wellgistics Health (MEDS) Competitors

MEDS vs. RDGT, HKPD, MCK, COR, and CAH

How does Wellgistics Health compare to Ridgetech?

Summary

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Summary

How does Wellgistics Health compare to McKesson?

Summary

How does Wellgistics Health compare to Cencora?

Summary

How does Wellgistics Health compare to Cardinal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEDS vs. The Competition

Wellgistics Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Wellgistics Health (MEDS) Competitors

MEDS vs. RDGT, HKPD, MCK, COR, and CAH

How does Wellgistics Health compare to Ridgetech?

Which has higher valuation & earnings, RDGT or MEDS?

Does the media favor RDGT or MEDS?

Which has more risk and volatility, RDGT or MEDS?

Do insiders & institutionals have more ownership in RDGT or MEDS?

Is RDGT or MEDS more profitable?

Do analysts prefer RDGT or MEDS?

Summary

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Do insiders & institutionals hold more shares of HKPD or MEDS?

Does the media prefer HKPD or MEDS?

Which has more volatility & risk, HKPD or MEDS?

Which has stronger valuation & earnings, HKPD or MEDS?

Do analysts rate HKPD or MEDS?

Is HKPD or MEDS more profitable?

Summary

How does Wellgistics Health compare to McKesson?

Which has stronger valuation and earnings, MEDS or MCK?

Is MEDS or MCK more profitable?

Does the media prefer MEDS or MCK?

Do institutionals & insiders believe in MEDS or MCK?

Which has more risk and volatility, MEDS or MCK?

Do analysts prefer MEDS or MCK?

Summary

How does Wellgistics Health compare to Cencora?

Is COR or MEDS more profitable?

Which has higher valuation and earnings, COR or MEDS?

Which has more risk & volatility, COR or MEDS?

Does the media prefer COR or MEDS?

Do institutionals and insiders have more ownership in COR or MEDS?

Do analysts prefer COR or MEDS?

Summary

How does Wellgistics Health compare to Cardinal Health?

Does the media favor CAH or MEDS?

Do insiders & institutionals believe in CAH or MEDS?

Which has stronger earnings and valuation, CAH or MEDS?

Which has more risk and volatility, CAH or MEDS?

Do analysts prefer CAH or MEDS?

Is CAH or MEDS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEDS vs. The Competition

Wellgistics Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools